Tag

Opdivo

healthcare

FDA Approves BMS’s Small Cell Lung Cancer Treatment
research & development

Bristol-Myers Squibb and Calithera Biosciences Expand Collaboration
healthcare vaccine

Bristol-Myers Squibb Receives Accelerated Approval of Opdivo (nivolumab) from the U.S. Food and Drug Administration